Drug Shortage Report for AMPICILLIN FOR INJECTION, USP
| Report ID | 226471 |
| Drug Identification Number | 02227029 |
| Brand name | AMPICILLIN FOR INJECTION, USP |
| Common or Proper name | AMPICILLIN FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 mL |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-23 |
| Estimated end date | 2024-05-07 |
| Actual end date | 2024-05-15 |
| Shortage status | Resolved |
| Updated date | 2024-05-16 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Ampicillin for Injection 250 mg SD Vial 10 mL effective April 23, 2024, until May 15, 2024. During this time, our Ampicillin for Injection 500 mg SD Vial 10 mL will be available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-05-16 | English | Compare |
| v4 | 2024-05-08 | French | Compare |
| v3 | 2024-05-08 | English | Compare |
| v2 | 2024-04-29 | French | Compare |
| v1 | 2024-04-29 | English | Compare |
Showing 1 to 5 of 5